
Calumet Inc (CLMT) shares have risen to $23.57, surpassing the average analyst 12-month target price of $22.70. This move typically prompts analysts to either downgrade on valuation or raise their targets, signaling to investors a critical juncture for reassessing whether the current valuation is sustainable or if further upside is warranted. The stock currently holds an average analyst rating of 1.67, driven by 4 Strong Buy and 2 Hold recommendations from the 5 analysts covering it.
Calumet Inc. (CLMT) has reached a critical inflection point, with its share price of $23.57 surpassing the average 12-month analyst price target of $22.70. This event typically forces analysts to either upgrade targets, suggesting continued fundamental strength, or downgrade based on valuation. The current analyst landscape for CLMT is characterized by a significant divergence in opinion; while the consensus rating is a bullish 1.67 (out of 5) based on four "Strong Buy" and two "Hold" ratings, individual price targets show high dispersion, ranging from $15.00 to $29.00 with a standard deviation of $5.761. This indicates a lack of consensus on the company's ultimate valuation. Notably, the analyst ratings have remained static for the past three months, suggesting the market's recent price appreciation has outpaced the formal analyst review cycle, putting pressure on analysts to issue updated guidance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment